FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

David Cohen, Timothy Maughan, Gareth Griffiths, Sarah Burns, Simon Noble, Fergus Macbeth

Research output: Contribution to journalArticlepeer-review

82 Downloads (Pure)

Fingerprint

Dive into the research topics of 'FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences